Preventive pneumococcal vaccination should be considered for those with celiac disease, with special attention to those aged 15-64 years who have not received the scheduled pneumococcal vaccination series as a child. Celiac disease (CD) is an autoimmune disorder triggered by gluten in genetically susceptible individuals characterized by a variable combination of gluten-dependent symptoms, presence of specific autoantibodies and enteropathy. However, the fast production of COVID-19 vaccines has caused concern among the general public regarding their safety and efficacy. Both currently approved mRNA vaccines require two doses to be effective, while the DNA vaccine requires one dose. Researchers are studying a vaccine that could protect people with celiac disease from accidental exposure to gluten. The health burden of CD is considerable, as it reduces quality of life and, at a societal level, has extensive negative economic consequences. Beyond celiac disease, the finding sets the stage for the technology — a nanoparticle containing the antigen triggering the allergy or autoimmune disease — to treat a host of other diseases and allergies including multiple sclerosis, type 1 diabetes, peanut allergy, asthma and more. Both currently approved mRNA vaccines (Moderna and Pfizer) require two doses to be effective, while the DNA vaccine (Johnson and Johnson) requires one dose. If it's verified in future studies, it means a simple vaccine might be enough to protect children from gluten intolerance later in life. With the recent news that the Food and Drug Administration has granted Emergency Use Authorization for a vaccine against SARS-CoV-2, the virus that causes Covid-19, patients with celiac disease are asking for guidance about the advisability of this and other Covid-19 vaccines in the context of celiac disease, an immune-mediated condition. COVID-19 Vaccine Recommendations for those with Celiac Disease. Everyone 16 years of age and older is now eligible to get a COVID-19 vaccination. Widespread vaccination is a critical tool to help stop the pandemic. Beyond Celiac encourages all members of the celiac disease community to receive a COVID-19 vaccine as soon as they are able. A breakthrough vaccine, which is currently being trialled in Perth, claims it could help people with coeliac disease to eat gluten without getting ill. COVID-19 vaccines may be administered to most people with underlying medical conditions. (1) Background: COVID-19 vaccination campaigns offer the best hope of controlling the pandemic. Get a COVID-19 vaccine as soon as you can. Beyond Celiac encourages all members of the celiac disease community to receive a COVID-19 vaccine as soon as they are able. Since celiac disease (CD) is also strongly associated with the same haplo-type it may be hypothesized that celiac patients are less able to respond to the vaccine. In particular, patients with chronic illnesses, such as celiac disease (CD), may be more fearful. Celiac disease is an autoimmune condition where the immune system starts attacking the lining of a patient's small intestine every time it's exposed to even the tiniest amount of gluten. Celiac disease is associated with an increased risk of pneumococcal infection. The vaccine … Within the celiac disease population, those who had not been vaccinated were found to have a 28% higher chance of contracting pneumonia than those who had received the vaccine.